Details of the Drug

General Information of Drug (ID: DMV574J)

Drug Name
CSL312
Synonyms Garadacimab
Indication
Disease Entry ICD 11 Status REF
Hereditary angioedema 4A00.14 Phase 3 [1]
Drug Type
Antibody
Cross-matching ID
UNII
32W6AJL0DY
DrugBank ID
DB15629
TTD ID
DR49KB

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Coagulation factor XII (F12) TTMXD0O FA12_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04656418) CSL312 (Garadacimab) in the Prevention of Hereditary Angioedema Attacks. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of CSL Behring.